[HTML][HTML] Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium
RK Gupta, EL Nwachuku, BE Zusman, RM Jha… - Plos one, 2021 - journals.plos.org
Drug repurposing has the potential to bring existing de-risked drugs for effective intervention
in an ongoing pandemic—COVID-19 that has infected over 131 million, with 2.8 million …
in an ongoing pandemic—COVID-19 that has infected over 131 million, with 2.8 million …
Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium.
RK Gupta, EL Nwachuku, BE Zusman, RM Jha… - PLoS ONE, 2021 - go.gale.com
Drug repurposing has the potential to bring existing de-risked drugs for effective intervention
in an ongoing pandemic-COVID-19 that has infected over 131 million, with 2.8 million …
in an ongoing pandemic-COVID-19 that has infected over 131 million, with 2.8 million …
[HTML][HTML] Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium
RK Gupta, EL Nwachuku, BE Zusman, RM Jha… - PLoS ONE, 2021 - ncbi.nlm.nih.gov
Drug repurposing has the potential to bring existing de-risked drugs for effective intervention
in an ongoing pandemic—COVID-19 that has infected over 131 million, with 2.8 million …
in an ongoing pandemic—COVID-19 that has infected over 131 million, with 2.8 million …
Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium
RK Gupta, EL Nwachuku, BE Zusman, RM Jha… - PloS …, 2021 - scholar.barrowneuro.org
Drug repurposing has the potential to bring existing de-risked drugs for effective intervention
in an ongoing pandemic-COVID-19 that has infected over 131 million, with 2.8 million …
in an ongoing pandemic-COVID-19 that has infected over 131 million, with 2.8 million …
[PDF][PDF] Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium
RK Gupta, EL Nwachuku, BE Zusman, RM Jha… - PLoS ONE, 2021 - scienceopen.com
Drug repurposing has the potential to bring existing de-risked drugs for effective intervention
in an ongoing pandemic—COVID-19 that has infected over 131 million, with 2.8 million …
in an ongoing pandemic—COVID-19 that has infected over 131 million, with 2.8 million …
Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium
RK Gupta, EL Nwachuku, BE Zusman, RM Jha… - PLOS …, 2021 - econpapers.repec.org
Drug repurposing has the potential to bring existing de-risked drugs for effective intervention
in an ongoing pandemic—COVID-19 that has infected over 131 million, with 2.8 million …
in an ongoing pandemic—COVID-19 that has infected over 131 million, with 2.8 million …
[引用][C] Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium
RK Gupta, EL Nwachuku, BE Zusman, RM Jha… - PLoS …, 2021 - ui.adsabs.harvard.edu
Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced
gene signature in human airway epithelium - NASA/ADS Now on home page ads icon ads …
gene signature in human airway epithelium - NASA/ADS Now on home page ads icon ads …
Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium.
RK Gupta, EL Nwachuku, BE Zusman, RM Jha… - PLoS …, 2021 - search.ebscohost.com
Drug repurposing has the potential to bring existing de-risked drugs for effective intervention
in an ongoing pandemic—COVID-19 that has infected over 131 million, with 2.8 million …
in an ongoing pandemic—COVID-19 that has infected over 131 million, with 2.8 million …
Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium
RK Gupta, EL Nwachuku, BE Zusman, RM Jha… - PloS …, 2021 - pubmed.ncbi.nlm.nih.gov
Drug repurposing has the potential to bring existing de-risked drugs for effective intervention
in an ongoing pandemic-COVID-19 that has infected over 131 million, with 2.8 million …
in an ongoing pandemic-COVID-19 that has infected over 131 million, with 2.8 million …
[PDF][PDF] Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium
RK Gupta, EL Nwachuku, BE Zusman, RM Jha… - PLoS ONE, 2021 - scholar.archive.org
Drug repurposing has the potential to bring existing de-risked drugs for effective intervention
in an ongoing pandemic—COVID-19 that has infected over 131 million, with 2.8 million …
in an ongoing pandemic—COVID-19 that has infected over 131 million, with 2.8 million …